z-logo
open-access-imgOpen Access
Antibody Response to the 60‐kDa Heat‐Shock Protein ofChlamydia pneumoniaein Patients with Coronary Artery Disease
Author(s) -
Christian A. Jantos,
Cathrin Krombach,
Frederik N. Wuppermann,
Andreas Gardemann,
Sven Bepler,
Haydar Asslan,
Johannes H. Hegemann,
Werner Haberbosch
Publication year - 2000
Publication title -
the journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.69
H-Index - 252
eISSN - 1537-6613
pISSN - 0022-1899
DOI - 10.1086/315442
Subject(s) - chlamydophila pneumoniae , chlamydia , coronary artery disease , chlamydiaceae , antibody , chlamydiales , medicine , immunology , odds ratio , hsp60 , myocardial infarction , heat shock protein , biology , hsp70 , biochemistry , gene
Serum specimens from 752 individuals undergoing coronary arteriography were examined for antibodies to Chlamydia pneumoniae. Patients with coronary artery disease (CAD) were more likely to have IgG antibodies to C. pneumoniae than were individuals without CAD (60% vs. 52%; P=.007; odds ratio, 1.8; 95% confidence interval, 1. 17-2.77). Antibodies to recombinant hsp60 of C. pneumoniae were found with nearly the same frequency in patients with CAD and individuals without CAD (29% vs. 30%; P=.751). There was no association between chlamydial hsp60 antibodies and the severity of CAD or a previous myocardial infarction. Patient sera reacted most frequently to C. pneumoniae proteins of 17, 38, 40, 58, and 60/62 kDa. Reactivity to these proteins was not different between patients with and without CAD. Study results indicate that neither antibodies to chlamydial hsp60 nor antibodies to other C. pneumoniae proteins are useful for discriminating between seropositive patients with and without CAD.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom